Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 22.
Published in final edited form as: Asian J Surg. 2023 Mar 16;46(8):3225–3227. doi: 10.1016/j.asjsur.2023.03.019

Characteristics of intussusception among children <24 months old before rotavirus vaccine introduction in Lao PDR

Vannida Douangboupha 1, Savina Vorasane 2, Souksavath Sivixay 3, Chaysavanh Thammavong 1, Thonglay Vongphacachanh 1, Vongphet Soulithone 4, Sanyalack Saysanasongkham 4, Inthaxay Sisanon 4, Sousada Narongsack 5, Soumalay Chankongsine 5, Sourith Sydasak 5, Viengpeht Yathotou 2, Lauren Franzel-Sassanpour 6, Umesh D Parashar 7, Jacqueline E Tate 7, Margaret Cortese 7, Eleanor Burnett 7
PMCID: PMC10958621  NIHMSID: NIHMS1972908  PMID: 36933965

To the editor:

Intussusception, the invagination of the bowel into a distal segment, is the most common cause of acute bowel obstruction in infants [1]. Nearly all intussusception cases require either enema or surgical reduction and untreated intussusception can result in death. Typically, the cause of naturally occurring intussusception is unknown but rotavirus vaccines are associated with a small elevated risk of intussusception in some settings [2]. In preparation for rotavirus vaccine introduction, we describe intussusception epidemiology and management in Lao PDR.

From December 2018 through September 2020, we prospectively enrolled children <24 months old admitted to any of the three sentinel surveillance hospitals in Lao PDR for intussusception meeting the Brighton level 1 criteria [3]. Children were identified by surveillance staff who gathered standardized information from the children’s families and medical records. We compared children by enema and surgical management. We also compared the period before (December 1, 2018 through February 29, 2020) and during (March 1, 2020 through September 30, 2020) the COVID-19 pandemic. We assessed differences by the Mantel-Haenszel chi square and rank sum tests; p-values <0.05 were considered statistically significant. This activity was considered routine public health surveillance and non-research by the institutional review board at the US Centers for Disease Control and Prevention. This study received ethic approval (ID 2018.119.MC; 117/NECHR (31 Dec 2018)) from the National Ethic Committee for Health Research (NECHR), Lao PDR.

Twenty-eight (48%) of the 58 children included in this analysis were managed with enema reduction and 30 (52%) were managed surgically, of whom 3 (10%) had bowel resection (Table 1). No seasonality was observed in case enrollment. Overall, 32 (55%) of cases were male. The median age was 14.5 months (IQR: 8.5–19 months) among children managed by enema and 8 months (IQR: 6–19 months) among children managed surgically. Children managed surgically were transferred more frequently (surgery: n=13, 43%; enema: n=5, 18%; p=0.038) and had a longer median transfer interval (surgery: 1.5 days, IQR: 0.5–2 days; enema: 0 days, IQR: 0–0 days; p=0.112), and hospitalization (surgery: 6 days, IQR: 4–8 days; enema: 1 day, IQR: 0–1 days; p<0.001). There was no difference in the proportion requiring surgery before or during the COVID-19 pandemic (before: n=17 of 35, 49%; during: n=13 of 23, 57%; p=0.557). None of the children died or had received rotavirus vaccine.

Table 1.

Characteristics of intussusception cases <24 months old and comparison by treatment modality, Lao PDR 2018–2020

Total Enema Surgery p-value1
N=58 % N=28 % N=30 %
Sex Male 32 55 14 50 18 60 0.448
Female 26 45 14 50 12 40
Age (months) Median, IQR2 12 7–19 14.5 8.5–19 8 6–18 0.132
Ever breastfed3 51 89 23 85 28 93 0.408
Chronic medical condition 0 0 0 0 0 0 -
Had been transferred to the surveillance hospital 18 31 5 18 13 43 0.038
Days from symptom onset to transfer Median, IQR2 1 0–2 0 0–0 1.5 0.5–2 0.112
Outcome Discharged 58 100 28 100 30 100 -
Died 0 0 0 0 0 0
Duration of hospitalization at surveillance hospital (days) Median, IQR2 2.5 1–6 1 0–1 6 4–8 <0.001
Surveillance hospital Mahosot Hospital 43 74 24 86 19 63 0.024
Children’s Hospital 11 19 4 14 7 23
Champasak Hospital 4 7 0 0 4 13
Admission before or during COVID-19 pandemic Before (Dec 2018-Feb 2020) 35 60 18 64 17 57 0.557
During (Mar 2020-Sep 2020) 23 40 10 36 13 43
Symptoms at time of admission Any of the list below 54 93 24 86 30 100 0.033
Fever 17 29 4 14 13 43 0.016
Diarrhea3 33 57 14 50 19 63 0.358
Vomiting 45 78 18 64 27 90 0.020
Constipation4 10 17 3 11 7 23 0.177
Bloody stool 31 53 10 36 21 70 0.010
Days from symptom onset to admission to surveillance hospital Median, IQR2 0 0–1 0 0–1 1 0–2 0.044
Complications Any 3 5 1 4 2 7 0.498
Wound infection 0 0 NA 0 0 0
Would dehiscence 0 0 NA 0 0 0
Peritonitis 1 2 1 4 0 0
Secondary Obstruction 2 3 0 0 2 7
Other 0 0 0 0 0 0
1

p-value calculated from chi-squared for categorical variables or rank sum test for continuous variables

2

Interquartile range

3

1 missing

4

2 missing

To our knowledge, this is the first intussusception surveillance report from Lao PDR and one of the first globally during the COVID-19 pandemic. These findings point to important differences between enema and surgical management of intussusception. While no child died, the invasiveness of surgery and the burden of extended hospitalizations are important considerations. As intussusception sensitization is expected to be part of rotavirus vaccine introduction, this is an opportunity to increase awareness of intussusception. It is noteworthy that the COVID-19 pandemic did not interrupt surveillance. It has been hypothesized that SARS-COV-2 can cause intussusception [4], however we were unable to assess this. Understanding the local intussusception epidemiology and treatment patterns will be useful for rotavirus vaccine preparation.

Footnotes

Conflicts of interest: The authors indicate that they have no conflicts of interest relevant to this article to disclose.

Disclaimer: The findings and conclusions of this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.

References

  • [1].Acute intussusception in infants and children: incidence, clinical representation and management: a global perspective. In: Va Biologicals, editor.: World Health Organization; 2002. [Google Scholar]
  • [2].Reddy SN, Nair NP, Tate JE, Thiyagarajan V, Giri S, Praharaj I, et al. Intussusception after Rotavirus Vaccine Introduction in India. N Engl J Med. 2020;383:1932–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Bines JE, Kohl KS, Forster J, Zanardi LR, Davis RL, Hansen J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22:569–74. [DOI] [PubMed] [Google Scholar]
  • [4].Scottoni F, Giobbe GG, Zambaiti E, Khalaf S, Sebire NJ, Curry J, et al. Intussusception and COVID-19 in Infants: Evidence for an Etiopathologic Correlation. Pediatrics. 2022. [DOI] [PubMed] [Google Scholar]

RESOURCES